Nurix Therapeutics Inc (NRIX)

Finanzdaten der Nurix Therapeutics Inc-Aktie (NRIX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-02-29	2023-11-30	2023-08-31	2023-05-31	2023-02-28
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	9.41% 16.59	15.16	18.47	30.68	12.69
Operating Expenses	2.17% 61.80	60.49	58.48	57.44	55.64
Benefits Costs and Expenses	73.74% 58.01	220.94	-	-	-
Costs And Expenses	17.49% 58.01	49.38	58.48	57.44	55.64
Depreciation and Amortization	5.74% 2.045	1.934	1.951	1.896	1.752
Operating Income/Loss	0.25% -45.22	-45.33	-40.01	-26.77	-42.95
Income/Loss From Continuing Operations Before Tax	79.87% -41.43	-205.78	18.47	-24.28	-40.73
Income Tax Expense/Benefit	0.09	-	-	-	-
Income/Loss From Continuing Operations After Tax	1.04% -41.52	-41.96	-36.98	-24.28	-40.73
Net Income/Loss	1.04% -41.52	-41.96	-36.98	-24.28	-40.73
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	49,627% 54.90	0.1104	54.39	54.26	54.03
Diluted Average Shares	49,627% 54.90	0.1104	54.39	54.26	54.03
Basic Earnings Per Share	1.30% -0.76	-0.77	-0.68	-0.45	-0.75
Diluted Earnings Per Share	1.30% -0.76	-0.77	-0.68	-0.45	-0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-